I expressed that very sentiment in my letter to Humanigen yesterday.
"I hope it will not be necessary to take the hand of Gilead or some other Big Pharma. But I know that will be a matter of our alternatives."
And by the way, we are now back to trading at a share price that is 5x that of CYDY, whose market cap is now more than twice ours. That means on a pre-reverse split basis, we are trading at the same price as CYDY. I don't know why that thought popped into my head after mentioning Gilead and Big Pharmas in the previous paragraph, but for some reason, it did.
We have been well-played.
Market Data 
Markets 
AI
